Blood Transfusion Diagnostics Market: Advanced Diagnostic Technologies Driving Growth Through 2033
The global Blood Transfusion Diagnostics Industry is experiencing robust growth driven by the rising frequency of organ transplantations, surgical interventions, trauma cases, and the increasing global burden of chronic hematological diseases requiring safe and compatible blood products. According to Business Market Insights, the global Blood Transfusion Diagnostics Market size is expected to reach US$ 8.7 Billion by 2033 from US$ 5.26 Billion in 2025. The market is estimated to record a CAGR of 6.49% from 2026 to 2033. Technological advancement is continuously shaping the immunohematology landscape, with a strong focus on automated high-throughput analyzers, precision Nucleic Acid Testing (NAT), and extended molecular genotyping. Diagnostic manufacturers are rapidly innovating to produce highly sensitive screening assays and smart, IoT-enabled platforms that allow blood banks to detect transfusion-transmitted infections earlier, optimize donor-recipient crossmatching, and meet s...